Xconomy | Boston - Business + Technology in the Exponential Economy

Escoublac Inc. Lands $6,650,000 Series A Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c82448c4-58ab-49c4-90b6-db34f2072c76&Preview=1
Date
1/10/2008
Company Name
Escoublac Inc.
Mailing Address
14 Cambridge Center Cambridge, MA 02142
Company Description
Escoublac was established based on the discovery that osteocalcin, a protein found in bone and dentin, plays a role in energy metabolism and related disorders. The research findings, published in the August 2007 issue of the peer-reviewed scientific journal Cell, demonstrated that osteocalcin encouraged weight loss, increased the production of insulin-generating beta cells as well as insulin, and improved sensitivity to insulin. The company aims to transform this discovery into new therapies for metabolic disorders and related conditions, such as obesity and type 2 diabetes.
Website
http://www.escoublac.com/
Transaction Type
Venture Equity
Transaction Amount
$6,650,000
Transaction Round
Series A
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
Undisclosed